Only a few cases of pneumocystis pneumonia (PCP) in Cushing's syndrome have been published in the literature so far. In the majority of these patients, the pneumonia occurred after reduction of the hypercortisolism with medicamentous treatment. We report two cases of PCP during conservative treatment of hypercortisolism.
CASe RePORT introduction
The immunosuppressive effect of corticosteroids is well known and thus they are widely implemented in therapy. Opportunistic infections have been reported to occur in endogenous hypercortisolism in Cushing's syndrome at a rate of incidence of 11-17%, the occurrence of which correlated with the severity of hypercortisolism (5, 6) . Several case reports have been published describing Pneumocystis pneumonia (PCP) in Cushing's syndrome. Patients with Cushing's syndrome are likely to have a subclinical Pneumocystis jiroveci infection that manifests upon restored immune response. The mechanism of Pneumocystis infection following cortisol-lowering therapy has been previously proposed (5, 6, 8) . We describe two cases of severe PCP in Cushing's syndrome and discuss the issue of primary antibiotic prophylaxis.
Case 1: Description
A 60-year-old woman was admitted to a district hospital for hyperglycemia 25 mmol/l (ref. range 3.3-5.6 mmol/l), polyuria with polydipsia and severe hypokalemia 2.1 mmol/l (ref. range 3.5-5.1 mmol/l). There was no significant pathology in her medical or family history, with the exception of smoking 10 cigarettes a day for 25 years and weight loss of 5 kg over the last month. She did not use any drug treatment. On physical examination, mild hypertension of 150/90 mmHg and muscle weakness were noted. Laboratory investigations revealed severe hypokalemia with alkalosis (HCO 3 − 38.1 mmol/l, Base excess 13.9 meq/l) (detailed results in Table 1) . A chest radiograph, echocardiography and abdominal ultrasonography were performed and revealed no pathology. Following consultation with a neurologist, mild polyneuropathy was diagnosed. Although potassium was supplemented aggressively, the serum potassium level remained low. The plasma cortisol level was above the upper limit of normal during the diurnal profile. After two weeks of hospitalization, the patient was transferred to our Department of endocrinology. 
Case 2: Description
A 20-year-old, previously healthy man was admitted to the intensive care unit for acute respiratory failure due to pneumonia and salmonella infection. One week before admission he suffered from a recent pathological fracture of the lumbar vertebrae prompting a diagnosis of severe osteoporosis. After recovery from the infection, he was transferred to our department for further evaluation. A CT scan showed decalcification of the vertebral column with compressive fractures. Hypercortisolism (>1380 nmol/l) was present in his laboratory results and other hormonal causes of osteoporosis were excluded -parathyroid hormone 18.2 pg/ml (ref.range 13-50 pg/ml), calcium 2 mmol/l (ref. range 2.17-2.65 mmol/l), ionized calcium 1.25 mmol/l (ref. range 0.9-1.3 mmol/l), free thyroxine 11.6 pmol/l (ref. range 11-25 pmol/l). There was no suppression of cortisol during a 2-day DST, UFC was 1188 nmol/24 h, ACTH 300 pg/ml, central hypogonadism was present and MRI showed pituitary microadenoma (see Figure 1) . Treatment was started with ketoconazole and ethomidate bromide, with good response in lowering hypercortisolism (from an immeasurable level over 1380 nmol/l to 425 nmol/l in four days). Unfortunately, a fever erupted. elevated inflammatory markers were found and pneumonia was detected on a chest radiograph (Figure 2 vided, four times a day) and broad-spectrum antimicrobial therapy. Pneumocystis pneumonia was confirmed by BAL but progression of respiratory failure demanded artificial ventilation. After recovery, the patient underwent radical pituitary adenomectomy. The hypercortisolism remained and both diabetes insipidus and panhypopituitarism developed. Further investigations should have been performed (high dose DST and inferior petrosal sinus sampling) and the pituitary surgery could have been avoided. The inferior petrosal sinus sampling was done only subsequently and did not show any gradient in ACTH secretion. The patient was indicated for bilateral laparoscopic epinephrectomy.
Positron emission tomography -computed tomography (PeT-CT) revealed foci of high metabolism in mediastinal lymph nodes, retrosternally, and in the lumbar spine. The octreoscan was negative. Biopsy of the lumbar vertebra revealed a metastasis of high-grade endocrine carcinoma with Ki-67 index of 30% and strong ACTH positivity (Figure 3) . Chemotherapy has been started with tumour remission.
discussion
Two cases of ectopic Cushing's syndrome (eCS) with manifestation of severe Pneumocystis pneumonia following cortisol-lowering therapy are described. P. jiroveci and a wide range of other opportunistic infections can occur in patients with hypercortisolism when the immune response is altered by the anti-inflammatory effect of glucocorticoids. It is supposed that alteration of immunity is glucocorticoids dose-dependent and the spectrum of opportunistic pathogens are the same in endogenous and exogenous hypercortisolism (4) . In Sarlis's retrospective analysis of patients with ectopic Cushing's syndrome (not due to small-cell lung carcinoma to avoid confounding factors), serum cortisol, urinary free cortisol (UFC) and daily urine 17-hydroxysteroid were higher and correlated in patients with severe infectious complication (9) . No correlation with temperature, white blood cell count, age, sex or localization of infection was observed. Higher levels of plasma cortisol in eCS are more common and the probability of infectious complications are more likely than in pituitary-dependent CS. An antibiotic prophylaxis has been suggested for P. jiroveci in patients with CS when plasma cortisol exceeds 2430 nmol/L (2). However, it seems difficult to determine any threshold. On the other hand, it seems that the fragile balance of the immune system is the cause of PCP manifestation after anti-inflammatory effects of steroids are attenuated. Asymptomatic carriage of pulmonary pneumocystis induced with cortisone acetate and development of pneumonia only after steroid withdrawal was demonstrated in rats (3). Thirty non-HIV cases of PCP after reversal of immunosuppression were described and reviewed previously, two of them with endogenous Cushing's syndrome (8) . The first case of PCP after initiation of octreotide and ketoconazole treatment in eCS was described by Kim et al. (6) . Later other cases were observed, with PCP after metyrapone in one patient (5), mifepristone in two eCS cases (10), after treatment with somatostatine analogue in eCS due to metastatic pancreatic islet cell carcinoma (7) and in other NeTs (1) . All authors suggest that prophylaxis should particularly be indicated in eCS. Generally, infection must be anticipated in patients with hypercortisolism and careful management with clinical monitoring is necessary. With respect to previous data and the fact that all clinical signs of infection can be attenuated in high cortisolemia, we conclude that PCP should be prevented in current practice. One possibility is commencing primary antibiotic prophylaxis in patients with high cortisolemia before medical treatment of hypercortisolism. Another prophylactic measure would be to screen patients for P. jiroveci by BAL or by induced sputum and only treat patients when P. jiroveci is detected.
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